跳至主要内容
临床试验/NCT02470598
NCT02470598已完成不适用

PD-Improved Dialysis Efficiency With Adapted APD - PD-IDEA

Fresenius Medical Care Deutschland GmbH50 个研究点 分布在 6 个国家目标入组 182 人开始时间: 2015年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
182
试验地点
50
主要终点
Hydration status

研究概览

简要总结

The aim of this study is to observe the effect of adapted APD (aAPD) on maintenance and/or improvement of the hydration status of more than 250 PD patients, and to observe the tolerability of the therapy over a long period.

详细描述

In some studies it has been observed that the use of a combination of short dwell/small volume and long dwell/large volume can improve the effectiveness of APD. However, these studies have been performed in a small number of patients during a short observation period.

The aim of this study is to assess the hydration status of PD patients treated with aAPD and observe its development during one year using the BCM-Body Composition Monitor (BCM), a bioimpedance spectroscopy (BIS) device. In addition, it is intended to observe the variability of aAPD prescriptions and their influence on the hydration status of the patients.

This is a purely non-interventional, observational study, where treatment decisions are completely guided by the discretion of the attending nephrologists.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • CKD patients with indication for renal replacement therapy
  • Patient treated or to be treated with aAPD
  • Fluid status regularly monitored with BCM

排除标准

  • Patients who have any condition prohibiting the use of BCM like patients with major amputations (e.g. lower leg)
  • Participation in an interventional study which could have an effect on the study objectives hydration status and dialysis adequacy (e.g. studies on PD solutions, studies on diuretics)

结局指标

主要结局

Hydration status

时间窗: Every three months during one year

Assessed via body composition measurements

次要结局

  • Residual renal function(Every three months during one year)
  • Changes in prescription(Every three months during one year)
  • Achievement of adequate solute removal(Every three months during one year)
  • Therapy tolerability(Every three months during one year)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (50)

Loading locations...

相似试验